EGFR and head and neck squamous cell carcinoma: For HNSCC, epidermal growth factor receptor (EGFR) has been identified as a suitable candidate and various exploratory preclinical and clinical trials have indicated the potential of this concept in aiding surgeons during head and neck tumor removal [18,19].